After Hours Summary: FC +9.8%, SONC +6.3%, FRAN -16.5%, PSMT -6.7%, BKS -3.8% following earnings/guidance/sales updatesAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: FC +9.8%, SONC +6.3%, AEHR +6% (also received an initial order from a new customer for its FOX-XP test and burn-in system for singulated bare die testing and burn-in of integrated silicon photonics devices for data communications applications), AMRN +5.7%, TTOO +3.9% (FDA clearance of T2Bacteria Panel remains on track for first quarter 2018; sees Q4 rev above prior guidance)
Companies trading higher in after hours in reaction to news: CNIT +64.4% (continued strength after closing at multiyear highs), WSCI +18.4% (DPW Holdings discloses 7.76% active stake; may engage in communications with management and Board ), CCIH +18.4% / CCCR +13.6% / CNET +1.7% (continued strength), DWCH +15.2% (higher following Reuters report that the company hired financial adviser), CFMS +10.1% (announced the publication of a prospective study in The Journal of Knee Surgery), AEHR +7% (received an initial order from a new customer for its FOX-XP test and burn-in system for singulated bare die testing and burn-in of integrated silicon photonics devices for data communications applications), YUME +6.6% (YuMe indicated higher after RhythmOne commenced exchange offer for outstanding YuMe shares pursuant to previously announced merger agreement), NQ +2.5% (still checking), TELL +2.5% and LNG +1.6% (initiated with Buy at Stifel), IONS +2.1% (being attributed to AVXS news), RTIX +1.2% (to acquire spine-focused medical device company Zyga Technology)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: FRAN -16.5% (lowers Q4 revenue guidance following disappointing holiday performance), OMED -9.5%, (CEO Paul J. Hastings resigns to pursue new career opportunities, effective January 1st, 2018; co also provides 2018 outlook), PSMT -6.7%, BKS -3.8% (reports total holiday sales -6.4% y/y to $953 mln; expects FY18 comps to decline in mid-single digits and EBITDA of $140 -160 mln)
Companies trading lower in after hours in reaction to news: RGNX -17.8%, (provides guidance with 2017 corporate update; had more than $175 mln in cash and equivalents to end the year; FY18 cash burn of $85-95 mln), NOVN -10.4% (commences common stock offering), SCYX -9.1% (thinly traded; provides a corporate update; Path forward established for iv program of SCY-078, with clinical trials to initiate in Q3 of 2018 with an improved IV formulation), HTGM -3.7% (after surging 75% higher today), AUPH -3.4% (filed preliminary short form base shelf prospectus to replace prior expired prospectus/corresponding shelf registration statement ), OKE -2.7% (to invest approximately $1.4 billion to construct a new pipeline, and related infrastructure, to transport natural gas liquids from the Rocky Mountain region to the company's existing Mid-Continent NGL facilities; launches 19 mln share common stock offering), AVXS -1.7% (to submit information requested by FDA to the IND on an on-going basis; plans to request a pre-BLA meeting in Q2 2018 ), M -1.2% (continued weakness)
